| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 15, 2021 | Sell(S) | 40K | $11.76 | $470K | 24K |
| Aug 16, 2021 | Option exercise(M) | 64K | $0.20 | $13K | 64K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 16, 2021 | Grant(A) | 36K | — | $0 | 36K |
| Aug 16, 2021 | Conversion(C) | 100K | $0.20 | $20K | 247K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000950142-21-003503) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NRX Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.